THE TREND
(Boursier.com) – The CAC40 started the session slightly up but now gives up a few points at the end of the morning (-0.1% to 7,210 points). After a fanfare start to the year and three sessions that brought it to new historical records of almost 7,400 points, the Parisian index remains in decline pending the season of annual publications. On Monday, Atos sent the wrong message with a new warning about its 2021 performance.
While absenteeism due to contamination with the Omicron variant is already disrupting several sectors of the economy, the Minister of the Economy and Finance Bruno Le Maire reaffirmed this Monday on the LCI channel, that “there is no of risk of paralysis, not of disorganization “. “In the long term, Omicron and the health situation will not affect French growth in 2022, which I maintain at 4%,” said Bruno Le Maire.
Isabel Schnabel, one of the ECB’s executive board members, said on Saturday that the ECB could respond if the rise in energy prices persisted, thus following in the wake of the firmer Fed rhetoric as has been seen. knows since last Thursday. The next big meeting for investors is set for Wednesday with the monthly statistics of US consumer prices, whose annual increase could reach 7% according to the Reuters consensus. The week will also be animated by the hearings of Jerome Powell and Lael Brainard in the Senate before the probable renewal of their mandate at the head of the Federal Reserve.
RISING VALUES
* Alstom (+ 1.7% to 33 euros) won a new order to supply DB Regio with 17 high-capacity Coradia Stream trains intended for the Main-Weser network in Germany. Commissioning is scheduled for December 15, 2024. Commissioning is scheduled for December 15, 2024. Alstom will assemble the trains at its site in Salzgitter, Germany.
* LVMH rose 0.3% to 718 euros on Monday, while the UBS broker raised its price target to 855 euros, against 736 euros previously.
* OSE Immuno jumped 7% to more than 10 euros, boosted by a recommendation from Degroof Petercam, the purchase on the record with a price target of 15.52 euros.
FALLING VALUES
* Eurofins Scientific fell almost 4% to 95 euros on Monday, while Jefferies lowered its recommendation to “keep” against a notice to “buy” previously. The broker has nevertheless adjusted its price target from 92 to 100 euros.
* Atos plunges 17% to 31.8 euros. The group has issued a warning on its annual results mainly because of items that it considers to be non-recurring. Compared to the objectives set last July, the management announced, for the 2021 financial year, a preliminary turnover of 10.8 billion euros, down around 2.4% at exchange rates. constant, an operating margin of around 4% and free cash flow of around -420 million euros. Results to be compared with the previous guidance, ie stable revenues, an operating margin of around 6% and a “positive” free cash flow.
* Hermes, which remains on two sessions of marked decline, still lost 2.2% to 1,415 euros at the start of the week. A selling pressure this time linked to a note from UBS which downgraded the title of the luxury group to ‘neutral’ despite an objective raised from 1,475 to 1,610 euros.
* CGG yields 3% to 0.72 euro. The turnover of the Group’s activities for the year 2021 is expected to be around $ 941 million. CGG forecasts positive 2021 net cash flow of approximately $ 15 million excluding cash debt refinancing costs.